Related Experiment Video
Updated: Jan 13, 2026

11:14
Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
12.1K
Novel Histopathologic Features of Diffuse Blue-Gray Hyperpigmentation Associated With Kratom Use: A Case Report and
Rita Kamoua1, Kristen Paradine1, Craig A Rohan1,2
1Wright State University Boonshoft School of Medicine, Fairborn, Ohio, USA.
Journal of Cutaneous Pathology
|January 8, 2026
Summary
Kratom (Mitragyna speciosa) use can cause drug-induced hyperpigmentation, a skin condition often misdiagnosed. This case highlights unique histopathological findings and the importance of considering herbal supplements in patient history.
Area of Science:
- Dermatology
- Toxicology
- Pharmacology
Background:
- Drug-induced hyperpigmentation is a significant cause of acquired pigmentary disorders.
- Kratom (Mitragyna speciosa) is increasingly used for pain, mood disorders, and opioid withdrawal, with known neuropsychiatric and liver toxicities.
- Skin changes, including hyperpigmentation, are poorly recognized adverse effects of Kratom.

